Biotech

All Articles

Turnstone gives up 60%, shocks C-suite to extend money

.Turnstone Biologics is actually lowering its head count by 60% as well as shocking its C-suite if y...

Gilead loses hope on $15M MASH bet after weighing preclinical data

.In a year that has actually found a confirmation as well as a boating of readouts for metabolic dys...

Texas biotech centers cancer cells pact, pins really hopes on being overweight

.Alaunos Therapeutics is actually axing an arrangement along with Precigen, quiting licensing rights...

Capricor reveals even more data for DMD therapy after initiating BLA

.Capricor Therapies is taking a triumph tour for their stage 2 Duchenne muscular dystrophy (DMD) tri...

FDA places Kezar lupus test in hold observing 4 patient fatalities

.The FDA has put Kezar Life Sciences' lupus test on grip after the biotech flagged four deaths durin...

Phase 3 Scholar Rock trial reaches SMA target, sending out stockpile 200%

.A phase 3 trial of Academic Rock's back muscle atrophy (SMA) applicant has reached its own main end...

CAMP 4 is actually most up-to-date to eye IPO, while Upstream point out $182M strategy

.RNA biotech CAMP4 Rehabs has defined plans for a $67 thousand IPO, along with inflammation-focused ...

Galecto acquires leukemia medication, loses bone cancer resource in pivot

.A year after the breakdown of an idiopathic pulmonary fibrosis applicant delivered Galecto on a loo...

Judo tosses down $100M to knock senseless kidney ailment

.Taking the mat is Judo Bio, a promising biotech armed with $100 million to build oligonucleotide me...

AstraZeneca spends CSPC $100M for preclinical heart problem medicine

.AstraZeneca has actually paid CSPC Pharmaceutical Group $100 million for a preclinical heart diseas...